ArticleJIMD reports2012

Treatment of Human Fibroblasts Carrying NPC1 Missense Mutations with MG132 Leads to an Improvement of Intracellular Cholesterol Trafficking.

Stefania Zampieri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.